BDBM50089270 CHEMBL308622::N-(1-Carbamoyl-2-phenyl-ethyl)-3-{2-[2-(2-{2-[2-(4-hydroxy-phenyl)-acetylamino]-hexanoylamino}-acetylamino)-3-(1H-indol-3-yl)-propionylamino]-hexanoylamino}-N-methyl-succinamic acid

SMILES CCCCC(NC(=O)Cc1ccc(O)cc1)C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCC)C(=O)NC(CC(O)=O)C(=O)N(C)C(Cc1ccccc1)C(N)=O

InChI Key InChIKey=RWRHDUZCTMMTIC-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50089270   

TargetCholecystokinin receptor type A(RAT)
Astrazeneca R&D Boston

Curated by ChEMBL
LigandPNGBDBM50089270(CHEMBL308622 | N-(1-Carbamoyl-2-phenyl-ethyl)-3-{2...)
Affinity DataKi:  51nMAssay Description:Inhibition of [125I]BH-CCK-8 binding to Cholecystokinin type A receptor of rat pancreatic tissueMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed